Patent details

EP1983984 Title: TUBEROUS SCLEROSIS TREATMENT

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP1983984
WO Application Number:
EP2007000818
Type:
European Patent Granted for NL
Status:
Revoked
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP07711417.1
WO Publication Number:
WO2007088034
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:

Dates

Filing date:
31/01/2007
Grant date:
07/03/2018
EP Publication Date:
29/10/2008
WO Publication Date:
09/08/2007
Claims Translations Received Date:
Claims Translation B1 Received Date:
29/05/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
07/03/2018
EP B1 Publication Date:
07/03/2018
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
30/01/2027
Lapsed By Expiration Date:
Patent Validated Date:
14/06/2018
Revocation Date:
31/10/2023
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
09/09/2020
 
 

 

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

Historical Applicant/holder

From:
26/09/2018
To:
09/09/2020

 

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

From:
26/09/2018
To:
09/09/2020

 

Name:
Novartis International Pharmaceutical AG
Address:
Lichtstrasse 35, 4056, Basel , Switzerland (CH)

From:
07/03/2018
To:
26/09/2018

 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 BASEL, Switzerland (CH)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
13/06/2018
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

1

Name:
BERG, William
Address:
New City, NY 10956, United States of America (US)

2

Name:
BENEDETTO, John
Address:
Morristown, NJ 07960, United States of America (US)

3

Name:
ELMROTH, Ingrid
Address:
CH-4125 Riehen, Switzerland (CH)

4

Name:
LANE, Heidi
Address:
CH-4105 Biel-Benken, Switzerland (CH)

5

Name:
LEBWOHL, David
Address:
Madison, NJ 07940, United States of America (US)

6

Name:
SELLERS, William
Address:
Chestnut Hill, MA 02467, United States of America (US)

7

Name:
STUMM, Michael
Address:
CH-4125 Riehen, Switzerland (CH)

Licensee

Name:
Novartis Pharma B.V.
From:
10/05/2019
Address:
Raapopseweg 1, 6824 DP, Arnhem, Netherlands (NL)
To:

Priority

1

Priority Patent Number:
0609698
Priority Date:
16/05/2006
Priority Country:
United Kingdom (GB)

2

Priority Patent Number:
0605760
Priority Date:
22/03/2006
Priority Country:
United Kingdom (GB)

3

Priority Patent Number:
0604593
Priority Date:
07/03/2006
Priority Country:
United Kingdom (GB)

4

Priority Patent Number:
0603568
Priority Date:
22/02/2006
Priority Country:
United Kingdom (GB)

5

Priority Patent Number:
0602123
Priority Date:
02/02/2006
Priority Country:
United Kingdom (GB)

Classification

IPC or IDT classification:
A61K 31/351; A61K 31/365; A61K 31/436; A61P 25/00; A61P 35/00;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
04/24
Publication date:
24/01/2024
Description:
Lapse or annulment

2

Bulletin Heading:
CO
Journal edition number:
39/20
Publication date:
23/09/2020
Description:
Changes in the Netherlands Patent Register

3

Bulletin Heading:
MED
Journal edition number:
25/19
Publication date:
19/06/2019
Description:
Other communications

4

Bulletin Heading:
VB1
Journal edition number:
02/19
Publication date:
09/01/2019
Description:
Requests for restoration and notices of objection, notices of objection to Court, notices of objection to appelate court ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention

5

Bulletin Heading:
CO
Journal edition number:
49/18
Publication date:
28/11/2018
Description:
Changes in the Netherlands Patent Register

6

Bulletin Heading:
EP3
Journal edition number:
26/18
Publication date:
20/06/2018
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

7

Bulletin Heading:
EP2
Journal edition number:
12/18
Publication date:
14/03/2018
Description:
European patents granted for the Netherlands

European Patent Bulletin

1

Issue number:
202404
Publication date:
24/01/2024
Description:
Revocation of the European patent

2

Issue number:
201902
Publication date:
09/01/2019
Description:
Opposition procedure started

3

Issue number:
201810
Publication date:
07/03/2018
Description:
Grant (B1)

Deed

Change of owner(s)

Change Kind/ Decision Type:
Merge
Deed Number:
RC202001757A
Date Registered:
09/09/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

2

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056 BASEL, Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Licence

Change Kind/ Decision Type:
New licence registration
Deed Number:
RC201900908A
Date Registered:
10/05/2019
License Effective Date:
10/05/2018
License Expiration Date:
Scope of License:
Not Exclusive
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Netherlands (NL)
Updated License Number:
Terminated License Number:

Added Licensee(s)

Name:
Novartis Pharma B.V.
Address:
Raapopseweg 1, 6824 DP, Arnhem, Netherlands (NL)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Change of owner(s)

Change Kind/ Decision Type:
Assignment
Deed Number:
RC201801726A
Date Registered:
26/09/2018
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:

Added Owner(s)

1

Name:
Novartis Pharma AG
Address:
Lichtstrasse 35, 4056, Basel, Switzerland (CH)

2

Name:
Novartis International Pharmaceutical AG
Address:
Lichtstrasse 35, 4056, Basel , Switzerland (CH)

Changed Pledgee

Name:
Address:

Removed Usufructuary

Name:
Address:

Added Usufructuary

Name:
Address:

Changed Usufructuary

Name:
Address:

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
26/12/2023
Last Annual Fee Paid Number:
18
Last Annual Fee Paid Amount:
1200 Euro
Payer:
Computer Patent Annuities Limited (CPA)
Filing date Document type Document Description Number of pages File Type
26/11/2018 Outgoing Correspondence Letter registration deed 1 PDF /4/0/6/5/4/0800245604/docs/ep07711417.1_0_241666l118.pdf
26/09/2018 Request for Change First filed deed 6 PDF /4/0/6/5/4/0800245604/docs/ep07711417.1_2_rfc20180928015249411.pdf
14/06/2018 Outgoing Correspondence Letter no formal defects 1 PDF /4/0/6/5/4/0800245604/docs/ep07711417.1_1_212496l271.pdf
29/05/2018 Claims First filed claims 1 PDF /4/0/6/5/4/0800245604/docs/ep07711417.1_3_claims20180529113949804.pdf
29/05/2018 Incoming Correspondence Electronic Accompanying letter incoming document 2 PDF /4/0/6/5/4/0800245604/docs/ep07711417.1_4_incomingcorrespondenceelectronic20180529113950875.pdf